e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Non-exhaled biomarkers in the assessment of airways disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Can blood eosinophils predict sputum eosinophils in stable COPD?
Netsanet Negewo (Newcastle, Australia), Netsanet Negewo, Vanessa McDonald, Katherine Baines, Peter Wark, Jodie Simpson, Paul Jones, Peter Gibson
Source:
International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Session:
Non-exhaled biomarkers in the assessment of airways disease
Session type:
Thematic Poster Session
Number:
3967
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Netsanet Negewo (Newcastle, Australia), Netsanet Negewo, Vanessa McDonald, Katherine Baines, Peter Wark, Jodie Simpson, Paul Jones, Peter Gibson. Can blood eosinophils predict sputum eosinophils in stable COPD?. Eur Respir J 2015; 46: Suppl. 59, 3967
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Blood eosinophils and outcomes in COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Relationship of blood eosinophil count to exacerbations in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
The relationship between blood eosinophils and bacterial load in COPD patients
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Biological markers of inflammation in asthma in children - eosinophils in sputum and ECP in peripheral blood
Source: Eur Respir J 2005; 26: Suppl. 49, 625s
Year: 2005
Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Peripheral blood eosinophilia predicts lower airway eosinophilia in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO.
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Eosinophils in peripheral blood are associated with eosinophils in sputum, BAL, and bronchial biopsies in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 306s
Year: 2004
Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002
Monitoring of sputum eosinophils in long-term treatment of bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 111s
Year: 2002
LATE-BREAKING ABSTRACT: Evaluating blood eosinophils and exacerbation history to predict ICS response in COPD
Source: International Congress 2016 – Late-breaking topics in airways disease
Year: 2016
Can red blood cell morphology be an indicator for COPD exacerbations?
Source: International Congress 2014 – Markers
Year: 2014
Evaluation of FeNo measurement as an alternative to sputum eosinophils in a severe asthma population
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma
Source: Annual Congress 2013 –Asthma
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept